Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, giving it access to a technology that allows patients’ own cells to generate therapies in the body without having to be extracted.The deal, announced on Monday, is the latest in a series of transactions the US drugmaker has signed in recent months […]
